drugset / Trial / NCT00617877
Antihypertensive Response to Losartan and Genetic Polymorphisms
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the antihypertensive response of treatment with losartan with reference to genetic polymorphisms.
Timeline
- Start
- 2005-03
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 100 mg | — |
| Background | Hydrochlorothiazide | Unknown | 25 mg | — |